When treating steroid-induced glaucoma, what is the OD required to do if the steroid was not prescribed by them?

When treating steroid-induced glaucoma, it is essential for the optometrist (OD) to inform the prescriber of the steroid treatment, especially if it was not prescribed by them. This action is critical for several reasons. Firstly, effective patient care relies on collaborative communication among healthcare providers. By informing the prescriber, the OD ensures that the prescribing physician is made aware of the side effects or complications that the patient may be experiencing from the steroid treatment, which could necessitate adjustments in therapy.

Additionally, steroids can significantly affect intraocular pressure, leading to potential vision loss if not monitored properly. The prescriber may need to reconsider the patient's current medications or overall treatment plan to manage the patient's glaucoma appropriately. By establishing this line of communication, the OD plays a vital role in the multidisciplinary approach to patient management, thereby enhancing patient safety and outcomes.

In contrast to this, simply notifying the patient or making independent decisions regarding medication adjustments does not promote the same level of coordinated care. While requesting a referral may be appropriate in some circumstances, effectively communicating with the original prescriber is a primary step that allows both practitioners to work together for the best interest of the patient.